Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Ongoing Initiated Feb 7, 2025 (2 years ago)

Alprostadil Container Description: Amber color bottle

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

CGMP Deviations

Cause type: cGMP deviation

Departures from current Good Manufacturing Practice found in production or during FDA inspection. A broad quality-system cause: the batch was made under conditions that fall short of FDA manufacturing standards. All cgmp deviation recalls.

What was recalled

Alprostadil Container Description: Amber color bottle

Drug: Alprostadil

Recalling firm
Aspen Biopharma Labs Pvt., Ltd.
Origin
India
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0261-2025 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall.

Other Alprostadil recalls

See all
Class III · Low risk

Alprostadil Injection USP 500 mcg/mL

Failed Impurities/Degradation Specifications; out-of-specification results for impurities obtained during routine stability testing

Terminated Impurity / degradation Teva Pharmaceuticals USA Inc NDC 0703-1501-02 D-0988-2022

Other recalls by Aspen Biopharma Labs Pvt., Ltd.

All 2025 recalls